Several asthma and allergy groups expressed "deep concern" over the recent FDA approval of Primatene MIST.
The new inhalation delivery system no longer includes CFC. It contains hydrofluroalkane (HFA) propellants and also features a built-in spray indicator and metal canister, replacing the glass container seen with the original Primatene Mist.
The ACCI includes questions about changes in asthma status, perceptions of disease burden, emergency room visits and hospitalizations, steroid use, adherence to prescribed medications, and symptom frequency.
Higher BMI in adults was related to an increase in moderate to severe upper respiratory infections.
Paradoxical bronchoconstriction is an underrecognized adverse event that can occur with administration of β2-agonist-containing inhaler formulations.
The overall rate of asthma-COPD overlap was 3.8%, with a maximum prevalence of 7.8% in Matlab, Bangladesh.
The use of chest radiographs in children with asthma who complain of chest pain should be limited, according to a new study.
Children exposed to cats, dogs, goats, cockroaches, and rats while in utero were more likely to develop asthma.
Time-series analysis based on geographic location revealed positive significant associations between asthma and influenza hospitalizations in Brooklyn and Manhattan.
The majority of study participants had rhinitis at baseline, including perennial allergic rhinitis with seasonal exacerbations, which is the most severe phenotype.
Changing to bronchodilator treatment with a metered dose inhaler in patients with mild to moderate asthma resulted in lower hospitalization rates, shorter hospital stays, and a decrease in continuous use of albuterol.
The FDA has approved Dupixent as an add-on maintenance treatment in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.
Total serum bilirubin levels of 9 to 11.9 mg/dL, 12 to 14.9 mg/dL, and 15 to 17.9 mg/dL were associated with significantly greater risks for asthma in infants.
Childhood non-atopic rhinitis is associated with an increased risk for adult asthma.
Children with asthma had a 66% higher risk for incident obesity compared with children without asthma.
Bronchial thermoplasty reduced gas trapping in individuals with asthma, particularly in patients with severe disease.
Infants who presented with pulmonary symptoms when diagnosed with gastroesophageal reflux disease had a higher incidence of early onset asthma compared with infants who did not have pulmonary symptoms.
Adolescents with asthma treated with dupilumab experienced significant improvements in FEV1 compared with placebo.
Patients with moderate to severe persistent allergic asthma who were treated with omalizumab experienced greater improvements in lung function after 16 weeks compared with those treated with placebo.
Montelukast plus levocetirizine demonstrated a significant reduction in mean daytime nasal symptom scores compared with montelukast monotherapy.
Benralizumab was associated with a significant reduction in annual asthma exacerbation rates.
Black and Hispanic respondents with asthma were less likely to use complementary alternative medicine than their white counterparts.
Disrupting regular combination inhaled corticosteroid therapy refills increased hospitalizations and exacerbations.
Regardless of severity, when children's asthma was appropriately managed according to guidelines, they experienced significant improvements.
A higher number of acute respiratory infections before the age of 2 may increase the risk for asthma by age 7.
Lower exposure to Proteobacteria in umbilical cord serum was associated with an increased risk for childhood wheezing.
African-American adolescents with asthma had improved outcomes when they received a comprehensive treatment plan.
The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer.
The PFS formulation eliminates the need to reconstitute the solution before administration.
For every 10-fold rise in methyl and propyl concentrations, there was a 2.61 and a 2.18 increased prevalence odds ratio, respectively, of reporting an emergency department visit in the last 12 months in boys with asthma.